Fox Chase Cancer Center

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Fox Chase Cancer Center

Thoracic Malignancies: A Review of the Latest Evidence
2022 Management of Early Stage Non-Small Cell Lung Cancer
2022 Optimizing Treatment Strategies for Localized and Advanced Prostate Cancer
19th Annual Highlights of the 2020 San Antonio Breast Cancer Symposium
Genitourinary Malignancies in the Time of COVID-19
Videos
2019 Updates in Bladder and Kidney Cancer
Bladder Kidney
Events

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time -0:00

0.5x
0.75x
1x, selected
1.25x
1.5x
1.75x
2x

Chapters

descriptions off, selected

captions settings, opens captions settings dialog
captions off, selected

This is a modal window.

Beginning of dialog window. Escape will cancel and close the window.

TextColorTransparency

BackgroundColorTransparency

WindowColorTransparency

Font Size

Text Edge Style

Font Family

End of dialog window.

10 seconds

Playback speed

This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.

Second Line Treatment Options in NSCLC

By Fox Chase Cancer Center FEATURING Hossein Borghaei

394 views

July 9, 2018

Comments 0

Hypothetical Patient Case: 1L Advanced Renal Cell Carcinoma With Mul…

Feat. R. Alter, A. Rezazadeh

Hypothetical Patient Case: RAI-R Metastatic Differentiated Thyroid C…

Feat. R. Alter, R. Shameem

Videos

ASCO® GU 2025 Summary: Perioperative Strategies in MIBC - Key Trial …

Insights from 2025 ASCO® GU Annual Meeting

E. Plimack

209 views

Pirtobrutinib in R/R B-Cell Malignancies: Newest Data From the BRUIN…

Fox Chase Cancer Center

S. Nakhoda

74 views

ESMO 2024 Summary: Important GU Trials - EV-103 5-Year Follow-Up (la…

2024 ESMO Annual Meeting Insights Hub

E. Plimack

232 views

ASCO® 2024 Insights: "The GIANT Trial (EA2186) - Gem & nab-Paclitaxe…

2024 ASCO® Annual Meeting Insights Hub

E. Dotan

753 views

LS-SCLC Updates - 2023 ASCO® Direct Philadelphia

Total Health

J. Bauman

83 views

Chemo vs. Chemo + Pembro in 1L Pleural Mesothelioma - 2023 ASCO® Dir…

Total Health

J. Bauman

234 views

ADAURA & KEYNOTE-671 Trials: Early Stage NSCLC Updates - 2023 ASCO® …

Total Health

J. Bauman

400 views

EHA® 2023 Insights: "An Outpatient Model for Teclistamab Step-Up Dos…

Insights from 2023 EHA® Annual Meeting

A. Varshavsky-Yanovsky

281 views

The Evolving Role of Dual Checkpoint Inhibition in Advanced NSCLC

2023 Texas Lung Cancer Conference Coverage

H. Borghaei

120 views

ASCO GU 2023 Adjuvant Therapies in Renal Cell Carcinoma: Are New Dat…

ASCO GU 2023 Conference Coverage

M. Zibelman

265 views

Adjuvant Treatment of NSCLC: ADAURA in Context

Fox Chase Cancer Center

M. Edelman

555 views

Influence of 1L Chemo on Survival Outcomes of Patients with Advanced…

Fox Chase Cancer Center

B. Miron

110 views

2L Treatment of Advanced Gastric Cancer: Moving Towards an Opportuni…

Fox Chase Cancer Center

N. Vijayvergia

416 views

2021 Update on Advanced Urothelial Cancer: Navigating 1L and Beyond …

Bladder Cancer Symposium: Update on Medical and Surgical Management for the Urologist

E. Plimack

47 views

Genotype-Directed Therapy for Advanced NSCLC: Overview of Targeted T…

3rd Annual Atlanta Precision Oncology Symposium

H. Borghaei

542 views

Targeted Therapy for Advanced NSCLC: Efficacy Analysis of RET, KRAS,…

3rd Annual Atlanta Precision Oncology Symposium

H. Borghaei

38 views

Immunology & IO in Lynch Syndrome: Immune System, MSI & Hereditary M…

UChicago Genetics in Clinical Cancer Care: From Family Reunions to the Frontline of Developmental Therapeutics

M. J. Hall

114 views

Genomic Differentiation of Early-Onset CRC: When Should the Screenin…

Fox Chase Cancer Center

J. Meyer

331 views

2020 Update on Radiation Therapy in Lung Cancer: Is High-Dose Twice-…

2020 ASCO Virtual Direct™ Highlights

H. Borghaei

327 views

2020 ASCO Update on Targeted Therapy in NSCLC: Is Adjuvant Osimertin…

2020 ASCO Virtual Direct™ Highlights

H. Borghaei

440 views

2020 ASCO Update on Advanced RCC: Pembrolizumab + Axitinib vs. Sunit…

Fox Chase Cancer Center

E. Plimack

30 views

The Role of IO in Bladder Cancer: Potential Benefits in Neoadjuvant …

GRACE

E. Plimack, R. Sedhom

278 views

GI Cancer Risks Associated with Pathogenic Variants (PV) in the Atax…

23rd Collaborative Group of the Americas on Inherited Colorectal Cancer Annual Meeting

M. Hall

27 views

2019 1st Line Systemic Therapy for Metastatic Urothelial Carcinoma: …

Fox Chase Updates in Bladder and Kidney Cancer 2019

E. Plimack

444 views

Front Line Therapy in NSCLC: Immunotherapy vs Immunotherapy + Chemo?

Fox Chase Cancer Center

H. Borghaei

228 views

I-O/Chemo Combination Therapies in NSCLC

Fox Chase Cancer Center

H. Borghaei

298 views

Second Line Treatment Options in NSCLC

Fox Chase Cancer Center

H. Borghaei

394 views